Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

Published:2020-11 Issue: Volume:162 Page:102186
ISSN:0952-3278
Container-title:Prostaglandins, Leukotrienes and Essential Fatty Acids
language:en
Short-container-title:Prostaglandins, Leukotrienes and Essential Fatty Acids

Author:

López-Neyra Alejandro,Suárez Lucrecia,Muñoz Marta,de Blas Ana,Ruiz de Valbuena Marta,Garriga María,Calvo Joaquim,Ribes Carmen,Girón Moreno Rosa,Máiz Luis,González David,Bousoño Carlos,Manzanares Javier,Pastor Óscar,Martínez-Botas Javier,del Campo Rosa,Cantón Rafael,Roy Garbiñe,Menacho Miriam,Arroyo David,Zamora Javier,Soriano Joan B,Lamas Adelaida

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry

Reference32 articles.

1. Inflammation and its genesis in cystic fibrosis;Nichols;Pediatr Pulmonol,2015

2. Inflammation in cystic fibrosis: An update;Roesch;Pediatr Pulmonol,2018

3. Early pulmonary inflammation in infants with cystic fibrosis;Khan;Am J Respir Crit Care Med,1995

4. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway;Karp;Nat Immunol,2004

5. Chemoattractants and cytokines in primary ciliary dyskinesia and cystic fibrosis: key players in chronic respiratory diseases;Cockx;Cell Mol Immunol,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of the Arachidonic Acid Pathway in Cystic Fibrosis: Implications for Chronic Inflammation and Disease Progression;Pharmaceuticals;2024-09-09

2. Impact of 1-Year Supplementation with High-Rich Docosahexaenoic Acid (DHA) on Clinical Variables and Inflammatory Biomarkers in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial;Nutrients;2024-03-27

3. Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial;Journal of Clinical Medicine;2023-05-26

4. Impact of omega‐3 supplementation on children and adolescents patients with cystic fibrosis: A systematic review and meta‐analysis of randomized‐controlled trials;Pediatric Pulmonology;2023-05-19

5. Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review;International Journal of Environmental Research and Public Health;2023-01-17